MedTrace Logo

China PEACE 5r-HF Study

NCT02877914 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 10000

Last updated 2017-12-06

No results posted yet for this study

Summary

This study will use a two-stage random sampling design to create a nationally representative sample of patients with heart failure (HF) in China. The investigators sought to describe the clinical profiles, to assess treatment patterns and in-hospital outcomes for HF, and to identify targets for care quality improvement.

Conditions

Interventions

OTHER

Observational study

This is a non-interventional study, patients receive their usual treatment as determined by the physician.

Sponsors & Collaborators

  • China National Center for Cardiovascular Diseases

    lead OTHER_GOV

Principal Investigators

  • Jing Li, MD, PhD · China National Center for Cardiovascular Disease

  • Harlan M Krumholz, MD, SM · Yale University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-09-30
Primary Completion
2018-04-30
Completion
2018-04-30

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02877914 on ClinicalTrials.gov